92 related articles for article (PubMed ID: 7826079)
21. Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer.
Francis PA; Rigas JR; Kris MG; Pisters KM; Orazem JP; Woolley KJ; Heelan RT
J Clin Oncol; 1994 Jun; 12(6):1232-7. PubMed ID: 7911159
[TBL] [Abstract][Full Text] [Related]
22. Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer.
Fossella FV; Lee JS; Murphy WK; Lippman SM; Calayag M; Pang A; Chasen M; Shin DM; Glisson B; Benner S
J Clin Oncol; 1994 Jun; 12(6):1238-44. PubMed ID: 7911160
[TBL] [Abstract][Full Text] [Related]
23. Phase II trial of docetaxel in Asian patients with inoperable stage III non-small cell lung cancer.
Goh BC; Lehnert M; Lim HL; Ng AW; Chan CC; Kong HL; Lee SC; Wee J; Chua ET; Wong JE
Acta Oncol; 2000; 39(2):225-9. PubMed ID: 10859016
[TBL] [Abstract][Full Text] [Related]
24. [Phase II study of docetaxel in inoperable advanced non small cell lung cancer].
Robinet G; Thomas P; Pérol M; Vergnenegre A; Lena H; Taytard A; Paillotin D; Bessa EH; Schuller-Lebeau MP
Bull Cancer; 2000 Mar; 87(3):253-8. PubMed ID: 10779813
[TBL] [Abstract][Full Text] [Related]
25. [A phase II study of CPT-11, a camptothecin derivative, in patients with primary lung cancer. CPT-11 Cooperative Study Group].
Negoro S; Fukuoka M; Niitani H; Suzuki A; Nakabayashi T; Kimura M; Motomiya M; Kurita Y; Hasegawa K; Kuriyama T
Gan To Kagaku Ryoho; 1991 May; 18(6):1013-9. PubMed ID: 1851408
[TBL] [Abstract][Full Text] [Related]
26. Docetaxel in stage III and IV non-small cell lung cancer.
Rigas JR
Eur J Cancer; 1995; 31A Suppl 4():S18-20. PubMed ID: 7577100
[TBL] [Abstract][Full Text] [Related]
27. Paclitaxel plus carboplatin in the treatment of patients with advanced lung cancer: a Vanderbilt University Cancer Center phase II trial (LUN-46).
Johnson DH; Paul DM; Hande KR; DeVore R
Semin Oncol; 1996 Dec; 23(6 Suppl 16):42-6. PubMed ID: 9007120
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of docetaxel in previously untreated extensive-stage small cell lung cancer: a Southwest Oncology Group phase II trial.
Hesketh PJ; Crowley JJ; Burris HA; Williamson SK; Balcerzak SP; Peereboom D; Goodwin JW; Gross HM; Moore DF; Livingston RB; Gandara DR
Cancer J Sci Am; 1999; 5(4):237-41. PubMed ID: 10439170
[TBL] [Abstract][Full Text] [Related]
29. Docetaxel (taxotere) extravasation: a report of five cases with treatment recommendations.
Ascherman JA; Knowles SL; Attkiss K
Ann Plast Surg; 2000 Oct; 45(4):438-41. PubMed ID: 11037169
[TBL] [Abstract][Full Text] [Related]
30. Docetaxel in combination with platinums in patients with advanced non-small-cell lung cancer.
Belani CP
Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):42-5. PubMed ID: 9364542
[TBL] [Abstract][Full Text] [Related]
31. Docetaxel and granulocyte colony-stimulating factor in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy: a multicenter phase II trial.
Alexopoulos K; Kouroussis C; Androulakis N; Papadakis E; Vaslamatzis M; Kakolyris S; Samelis G; Patila E; Vossos A; Samantas E; Georgoulias V
Cancer Chemother Pharmacol; 1999; 43(3):257-62. PubMed ID: 9923557
[TBL] [Abstract][Full Text] [Related]
32. Phase I study of docetaxel with concomitant thoracic radiation therapy.
Mauer AM; Masters GA; Haraf DJ; Hoffman PC; Watson SM; Golomb HM; Vokes EE
J Clin Oncol; 1998 Jan; 16(1):159-64. PubMed ID: 9440738
[TBL] [Abstract][Full Text] [Related]
33. An interesting antitumor drug in the elderly patients over the age of 70: weekly docetaxel.
Frontini L
Tumori; 2002; 88(1 Suppl 1):S41-3. PubMed ID: 11989922
[No Abstract] [Full Text] [Related]
34. Docetaxel (Taxotere) in combination with radiation therapy and the potential of weekly administration in elderly and/or poor performance status patients with advanced non-small cell lung cancer.
Hainsworth JD; Vokes EE
Semin Oncol; 2001 Feb; 28(1 Suppl 2):22-7. PubMed ID: 11284621
[TBL] [Abstract][Full Text] [Related]
35. Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group.
Fossella FV; DeVore R; Kerr RN; Crawford J; Natale RR; Dunphy F; Kalman L; Miller V; Lee JS; Moore M; Gandara D; Karp D; Vokes E; Kris M; Kim Y; Gamza F; Hammershaimb L
J Clin Oncol; 2000 Jun; 18(12):2354-62. PubMed ID: 10856094
[TBL] [Abstract][Full Text] [Related]
36. Paclitaxel and carboplatin in inoperable non-small cell lung cancer.
Kosmidis P; Mylonakis N; Fountzilas G; Samantas E; Athanasiadis A; Skarlos D
Semin Oncol; 1996 Dec; 23(6 Suppl 16):68-70. PubMed ID: 9007126
[TBL] [Abstract][Full Text] [Related]
37. Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer.
Chevallier B; Fumoleau P; Kerbrat P; Dieras V; Roche H; Krakowski I; Azli N; Bayssas M; Lentz MA; Van Glabbeke M
J Clin Oncol; 1995 Feb; 13(2):314-22. PubMed ID: 7844592
[TBL] [Abstract][Full Text] [Related]
38. Phase II study of docetaxel (taxotere) in patients with previously untreated extensive small cell lung cancer.
Latreille J; Cormier Y; Martins H; Goss G; Fisher B; Eisenhauer EA
Invest New Drugs; 1996; 13(4):343-5. PubMed ID: 8824354
[TBL] [Abstract][Full Text] [Related]
39. Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.
Belli L; LeChevalier T; Gottfried M; Adams D; Ruffie P; LeCesne A; Tete L; Pellae-Cosset B
Semin Oncol; 1995 Dec; 22(6 Suppl 15):29-33. PubMed ID: 8643967
[TBL] [Abstract][Full Text] [Related]
40. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
Hainsworth JD; Greco FA
Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
